TRVI

NASDAQStock

Trevi Therapeutics, Inc.

$10.98-0.21 (-1.92%)

52-Week Range

$5.28

$14.17

Key Stats

Market Cap

1.4B

P/E Ratio

—

Dividend Yield

—

Beta

0.99

Volume

733.8K

Avg Volume

1.3M

Performance

+7.69%

-11.18%

+40.70%

YTD

-5.80%

+71.25%

+518.78%

+302.88%

Price Chart

ETF Exposure

TRVI is held by 83 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
USFM.L	UBS MSCI USA Select Factor Mix UCITS ETF USD dis	0.00%	308	$4K	$134.4M	0.25%
DCOR	Dimensional - US Core Equity 1 ETF	0.00%	4,454	$50K	$2.68B	0.14%
EAOA	iShares ESG Aware 80/20 Aggressive Allocation ETF	0.00%	87	$1K	$33.4M	0.34%
IMID.L	State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)	0.00%	7,900	$80K	$5.16B	0.17%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	145,923	$1.7M	$80.22B	0.03%
IWV	iShares Russell 3000 ETF	0.00%	24,234	$289K	$17.30B	0.20%
SCHB	Schwab U.S. Broad Market ETF	0.00%	58,566	$688K	$37.50B	0.03%
SPYI.DE	State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)	0.00%	7,900	$68K	$4.48B	0.17%
VTI	Vanguard Total Stock Market ETF	0.00%	3,424,263	$35.9M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	18,010	$255K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	1,553	$22K	$1.29B	0.17%
ZPRV.DE	State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF	0.00%	2,152	$16K	$757.5M	0.30%
DFAS	Dimensional - US Small Cap ETF	0.00%	9,147	$102K	$12.65B	0.26%
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	9	$105	$8.9M	0.30%
EAOM	iShares ESG Aware 40/60 Moderate Allocation ETF	0.00%	11	$130	$8.2M	0.31%
EAOR	iShares ESG Aware 60/40 Balanced Allocation ETF	0.00%	59	$707	$29.8M	0.32%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	59	$700	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	49	$582	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	32	$384	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	24	$291	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	11	$129	$9.3M	0.12%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	6,014	$85K	$12.17B	0.24%
VTHR	Vanguard Russell 3000 ETF	0.00%	7,612	$80K	$5.50B	0.06%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	145,923	$137K	$14.63B	0.20%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	145,923	$42K	$3.91B	0.07%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	7,374	$83K	$40.55B	0.17%
DFUS	Dimensional - US Equity Market ETF	0.00%	2,157	$24K	$18.51B	0.09%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	8	$91	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	25	$302	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	43	$513	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	50	$591	$63.0M	0.11%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	168	$2K	$820.6M	0.25%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	29	$412	$337.7M	0.32%

PreviousPage 2 of 2

About TRVI ETF Exposure

Trevi Therapeutics, Inc. (TRVI) is held by 83 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.4B, TRVI is a widely held institutional stock. The stock currently trades at $10.98. Investors can gain exposure to TRVI through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TRVI, sorted by portfolio weight.